RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras?

Jung Won Lee, Andre J van Wijnen, Suk Chul Bae

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages321-332
Number of pages12
Volume962
DOIs
StatePublished - 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume962
ISSN (Print)00652598
ISSN (Electronic)22148019

Fingerprint

Tumors
Acetylation
Neoplasms
Phosphorylation
Oncogenes
DNA
DNA Damage
Automatic teller machines
Epithelial Cells

Keywords

  • ARF
  • DNA damage
  • Oncogene surveillance
  • p53
  • RUNX
  • Tumor suppressor

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lee, J. W., van Wijnen, A. J., & Bae, S. C. (2017). RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras? In Advances in Experimental Medicine and Biology (Vol. 962, pp. 321-332). (Advances in Experimental Medicine and Biology; Vol. 962). Springer New York LLC. https://doi.org/10.1007/978-981-10-3233-2_20

RUNX3 and p53 : How two tumor suppressors cooperate against oncogenic ras? / Lee, Jung Won; van Wijnen, Andre J; Bae, Suk Chul.

Advances in Experimental Medicine and Biology. Vol. 962 Springer New York LLC, 2017. p. 321-332 (Advances in Experimental Medicine and Biology; Vol. 962).

Research output: Chapter in Book/Report/Conference proceedingChapter

Lee, JW, van Wijnen, AJ & Bae, SC 2017, RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras? in Advances in Experimental Medicine and Biology. vol. 962, Advances in Experimental Medicine and Biology, vol. 962, Springer New York LLC, pp. 321-332. https://doi.org/10.1007/978-981-10-3233-2_20
Lee JW, van Wijnen AJ, Bae SC. RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras? In Advances in Experimental Medicine and Biology. Vol. 962. Springer New York LLC. 2017. p. 321-332. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-981-10-3233-2_20
Lee, Jung Won ; van Wijnen, Andre J ; Bae, Suk Chul. / RUNX3 and p53 : How two tumor suppressors cooperate against oncogenic ras?. Advances in Experimental Medicine and Biology. Vol. 962 Springer New York LLC, 2017. pp. 321-332 (Advances in Experimental Medicine and Biology).
@inbook{547b6e2bd7664f46a92a3e69da286b95,
title = "RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras?",
abstract = "RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.",
keywords = "ARF, DNA damage, Oncogene surveillance, p53, RUNX, Tumor suppressor",
author = "Lee, {Jung Won} and {van Wijnen}, {Andre J} and Bae, {Suk Chul}",
year = "2017",
doi = "10.1007/978-981-10-3233-2_20",
language = "English (US)",
volume = "962",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "321--332",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - RUNX3 and p53

T2 - How two tumor suppressors cooperate against oncogenic ras?

AU - Lee, Jung Won

AU - van Wijnen, Andre J

AU - Bae, Suk Chul

PY - 2017

Y1 - 2017

N2 - RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.

AB - RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.

KW - ARF

KW - DNA damage

KW - Oncogene surveillance

KW - p53

KW - RUNX

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85015365626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015365626&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-3233-2_20

DO - 10.1007/978-981-10-3233-2_20

M3 - Chapter

C2 - 28299666

AN - SCOPUS:85015365626

VL - 962

T3 - Advances in Experimental Medicine and Biology

SP - 321

EP - 332

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -